Adamantane as a Brain-Directed Drug Carrier for Poorly Absorbed Drug. 2. AZT Derivatives Conjugated with the 1-Adamantane Moiety
- 1 April 1994
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 83 (4), 481-484
- https://doi.org/10.1002/jps.2600830407
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Serum, Cerebrospinal Fluid, and Brain Concentrations of a New Zidovudine Formulation following Chronic Administration via an Implantable Pump in DogsJournal of Pharmaceutical Sciences, 1992
- Brain, Blood, and Cerebrospinal Fluid Distribution of a Zidovudine Chemical Delivery System in RabbitsJournal of Pharmaceutical Sciences, 1991
- Intra-Blood–Brain-Barrier Synthesis of HTLV-III-Specific IgG in Patients with Neurologic Symptoms Associated with AIDS or AIDS-Related ComplexNew England Journal of Medicine, 1985
- Isolation of HTLV-III from Cerebrospinal Fluid and Neural Tissues of Patients with Neurologic Syndromes Related to the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1985
- Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): Experience at UCSF and review of the literatureJournal of Neurosurgery, 1985
- HTLV-III Infection in Brains of Children and Adults with AIDS EncephalopathyScience, 1985
- Neurological complications of acquired immune deficiency syndrome: Analysis of 50 patientsAnnals of Neurology, 1983
- 4‐Dialkylaminopyridines as Highly Active Acylation Catalysts. [New synthetic method (25)]Angewandte Chemie International Edition in English, 1978
- Simple Method for the Esterification of Carboxylic AcidsAngewandte Chemie International Edition in English, 1978
- A Common Mode of Antiviral Action for Ammonium Ions and Various AminesNature, 1965